BioCentury
ARTICLE | Regulation

As U.S. joins U.K., Canada in authorizing BNT162b2 for COVID-19, all eyes turn to deployment 

Next up: Moderna

December 12, 2020 4:22 AM UTC

In a decision that marks a turning point in the most ambitious effort to apply science and technology to defeat an existential threat since World War II, FDA has joined regulatory agencies from the U.K. and Canada in authorizing use of a COVID-19 vaccine from BioNTech and Pfizer. 

It is the first emergency use authorization (EUA) for a COVID-19 vaccine in the U.S. and comes a week after the U.K. began to roll out BNT162b2 from Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX). Canada authorized the vaccine on Wednesday...